Update from Day 4
This conference has been very rich in terms of the diversity and depth of presentations. It is exciting to see the developments ongoing in our discipline as we develop the best ways to measure, monitor and manage the benefit-risk of medicines across the whole lifecycle of products.
The conference highlight for me from today was the plenary session on incorporating the patient perspective into clinical and pharmacoepidemiological research. The patient, academic and industry presentations captured the different perspectives and highlighted where we are on the journey of moving from “why” to “how” we incorporate the patient perspective.
2 quotes from the slide presentations are provided below
“Since patients will be the ones taking these medicines it makes absolute sense to incorporate their values and their knowledge at different stages throughout the long process of developing assessing, licensing and monitoring medicines”
Isabelle Moulon EMA
“It turns out that what is really bothering the patient and what is really bothering the doctor can be radically different things.”
Janet Woodcock, M.D. Director, Center for Drug Evaluation and Research FDA
Other highlights from today included the early morning walk down to Trinity College and a meal on the boat MV Cill Airne Boat Bar and Restaurant pictured in the collage above